Oral Complications of Head and Neck Cancer Therapy

Oral Complications of Head and Neck Cancer Therapy

Current therapies for Head and Neck cancer treatment are extremely advanced. Though, they cause oral complications which have deleterious effects on basic life functions, affect oral and overall health, may lead to significant morbidity and treatment discontinuation and have an impact on survivorshi...

Full description

Bibliographic Details
Main Authors:	Kouri Maria, Vadalouca Athina, Kouloulias Vasilios, Papadopoulou Erofili, Vardas Emmanouil, Kyrodimos Euthimios, Trichas Miltiadis, Galitis Evangelos, Zygogianni Anna, Liakouli Zoi, Nicolatou-Galitis Ourania, Psyrri Amanda
Format:	Article
Language:	English
Published:	Sciendo 2021-08-01
Series:	Forum of Clinical Oncology
Subjects:	oral complications head and neck cancer radiotherapy chemoradiotherapy targeted therapy immunotherapy
Online Access:	https://doi.org/10.2478/fco-2019-0016

Similar Items

Trismus and reduced quality of life in patients with oral squamous cell carcinoma, who received post-operative radiotherapy alone or combined with chemotherapy
by: Galitis Evangelos, et al.
Published: (2017-06-01)

Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
by: Muhammad Shahid Iqbal, et al.
Published: (2017-04-01)

Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy
by: Gunjesh Kumar Singh, et al.
Published: (2017-03-01)

Can zinc supplementation widen the gap between control and complications in head and neck cancer patients treated with concurrent chemo-radiotherapy
by: Mohsin Khan, et al.
Published: (2019-01-01)

Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary
by: Yazan Abu-Shama, et al.
Published: (2021-05-01)

A Retrospective Study of Reirradiation for Patients with Locoregional Recurrent Head and Neck Cancer: A Single-Institution Experience
by: Dina Salem, et al.
Published: (2016-06-01)

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
by: Jantien Hoek, et al.
Published: (2016-02-01)

The Impact of Active Nutritional Support for Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy
by: Vutisiri Veerasarn, et al.
Published: (2019-12-01)

Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
by: Yeona Cho, et al.
Published: (2018-10-01)

Outcome in radiographic complete regression of unresectable head and neck cancer with carotid artery encasement from induction chemotherapy followed by concurrent chemoradiotherapy: Case reports
by: Federico Ampil, et al.
Published: (2019-06-01)

Nutritional status and dietary quality index of head and neck cancer patients undergoing chemo radiotherapy
by: Shirin Fattahi, et al.
Published: (2020-02-01)

Reconstruction of the Head and Neck Region Using Lower Trapezius Musculocutaneous Flaps
by: Soo Kwang Yoon, et al.
Published: (2012-11-01)

The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
by: Daris Ferrari, et al.
Published: (2020-01-01)

Nutritional Care in Patients with Head and Neck Cancer during Chemoradiotherapy (CRT) and Bioradiotherapy (BRT) Provides Better Compliance with the Treatment Plan
by: Aleksandra Kapała, et al.
Published: (2021-05-01)

Identifying risk factors for L’Hermitte’s sign after IMRT for head and neck cancer
by: Hannah M. Laidley, et al.
Published: (2018-05-01)

Safety and efficacy of concurrent chemoradiotherapy for head-and-neck cancers in older versus younger patients: Post hoc analysis of a randomized controlled trial
by: Gunjesh Kumar Singh, et al.
Published: (2020-01-01)

Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
by: Hiromichi Shirasu, et al.
Published: (2020-03-01)

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice
by: Petr Szturz, et al.
Published: (2019-06-01)

Predictors of postradiation swallowing dysfunction in head-and-neck cancer
by: Romi Kant Grover, et al.
Published: (2018-01-01)

Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial
by: Sadamoto Zenda, et al.
Published: (2018-09-01)

Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2020-01-01)

Nutritional support as an obligatory component of accompanying therapy for head and neck tumors during radiotherapy and chemoradiotherapy
by: A. V. Boyko, et al.
Published: (2017-04-01)

Hypoxia in head and neck tumours: characteristics and development during therapy
by: Martin-Immanuel eBittner, et al.
Published: (2013-08-01)

Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial
by: Florence Legouté, et al.
Published: (2019-05-01)

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer
by: Petr Szturz, et al.
Published: (2019-02-01)

Time Factor and the Role of Gastrostomy Tube Placement in the Treatment of Advanced Head and Neck Tumors
by: Hajtmanova E., et al.
Published: (2011-08-01)

Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment
by: Francesca De Felice, et al.
Published: (2021-05-01)

Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck
by: Tomohiro Enokida, et al.
Published: (2018-08-01)

Gallotannin from <i>Bouea macrophylla</i> Seed Extract Suppresses Cancer Stem-like Cells and Radiosensitizes Head and Neck Cancer
by: Jiraporn Kantapan, et al.
Published: (2021-08-01)

A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx
by: Pei-Wei Huang, et al.
Published: (2018-04-01)

What Factors Affect Changes in Body Composition and Swallowing Function in Patients Hospitalized for Oral Cancer Surgery?
by: Kagifuku Y, et al.
Published: (2020-01-01)

Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication
by: Nafisha Lalani, et al.
Published: (2018-01-01)

Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial
by: Camilla K. Lonkvist, et al.
Published: (2017-06-01)

Different fractionation schedules of radiotherapy in locally advanced head and neck malignancy: A prospective randomized study to compare the results of treatment and toxicities of different protocols
by: Dipanjan Majumder, et al.
Published: (2013-01-01)

Impact of Early Supportive Care Assessment on treatment decision in head and neck cancer before concomitant chemoradiotherapy
by: Bisiaux, F., et al.
Published: (2022)

Competing Morbidities In Advanced Head And Neck Squamous Cell Carcinoma Concurrent Chemoradiotherapy: A Strong Implication Of A Multidisciplinary Team Approach
by: Lazzari G, et al.
Published: (2019-11-01)

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
by: Alexandre Arthur Jacinto, et al.
Published: (2018-10-01)

Dysphagia in Head and Neck Cancer Patients: Pretreatment Evaluation, Predictive Factors, and Assessment during Radio-Chemotherapy, Recommendations
by: Nerina Denaro, et al.
Published: (2013-09-01)

Radiotherapy for Head and Neck Cancer: Evaluation of Triggered Adaptive Replanning in Routine Practice
by: Metin Figen, et al.
Published: (2020-11-01)

Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study
by: T. Yokota, et al.
Published: (2017-05-01)

Cannot write session to /tmp/vufind_sessions/sess_r0fafhonor9bm04nst43op53ib